+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Hydroxyzine Imine Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 5012579
  • Report
  • April 2020
  • Region: Global
  • 117 pages
  • Mordor Intelligence


  • Alliance Pharma
  • GlaxoSmithKline
  • Pfizer
  • Teva Pharmaceuticals
  • MORE
The global hydroxyzine imine market is anticipated to witness a CAGR of nearly 5.1% during the forecast period. The increasing population with allergic reactions coupled with the geriatric population is among the key trends expected to trigger market growth. As per the Drug Database Statistic, hydroxyzine is among the top 100 brands and around 8 million prescriptions were given in the United States (2017), which is also boosting the market growth. Moreover, technological advancements with increasing investments in R&D for developing novel therapeutic drugs will also propel market growth. Increasing awareness regarding disease remittance therapies and rising healthcare expenditure in developed regions are estimated to promote revenue growth. However, side effects associated with this drug such as dizziness, skin rashes, and severe seizure may restrain the growth of the market.

Key Market Trends

Capsules​ Segment is Expected to Hold Significant Market Share in the Hydroxyzine imine Market

Capsules segment is expected to contribute significant market share attributing to ease of administration, ease of usage, easy availability and widely used in allergic reaction patients. Moreover, as hydroxyzine imine attenuates activity in the central nervous system, these properties helps hydroxyzine imine to treat anxiety associated with psychoneurosis. This is leading to adoptions of hydroxyzine imine capsules for several advantages such as stability in different ranges of temperature & humidity, physical stability, low hygroscopicity and low moisture content over others and thus boost the segment growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is at the forefront of growth in the region and is also an important revenue contributor in the global arena. Growing geriatric population with increasing allergic patients, high public and private healthcare spending are stimulating the growth of the region. As per the Centers for Disease control and prevention, an estimated 50 million Americans suffer from allergies each year and allergies are the 6th leading cause for chronic in the US, hence promote the revenue growth in this region.

Competitive Landscape

The Hydroxyimine Market is moderately competitive and consists of several global as well as local players.Some of the companies which are currently dominating the market are Teva Pharmaceuticals, Pfizer, GlaxoSmithKline, Alliance Pharma, Piramal Healthcare UK Limited.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Alliance Pharma
  • GlaxoSmithKline
  • Pfizer
  • Teva Pharmaceuticals
  • MORE
1.1 Study Assumptions
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Population with Allergic Reaction
4.2.2 Rise in Geriatric Population
4.2.3 Increasing Prevalence of Anxiety Disorders
4.3 Market Restraints
4.3.1 Side Effects associated with the Medication
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Dosage Form
5.1.1 Tablets
5.1.2 Capsules
5.1.3 Injection
5.1.4 Syrup
5.2 By Indication Type
5.2.1 Histamine-Mediated Pruritus
5.2.2 Urticaria
5.2.3 Atopic Contact Dermatoses
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Teva Pharmaceuticals
6.1.2 Pfizer
6.1.3 GlaxoSmithKline
6.1.4 Alliance Pharma
6.1.5 Piramal Healthcare UK Limited

Note: Product cover images may vary from those shown
  • Teva Pharmaceuticals
  • Pfizer
  • GlaxoSmithKline
  • Alliance Pharma
  • Piramal Healthcare UK Limited
Note: Product cover images may vary from those shown